| Overview |
| bsm-90138R |
| Retinoid X receptor alpha Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Retinoid X Receptor alpha |
| 1-41/462 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 6256 |
| P19793 |
| RXRA; Retinoid X Receptor Alpha; NR2B1; Nuclear Receptor Subfamily 2 Group B Member 1; Retinoic Acid Receptor RXR-Alpha; RXR-Alpha; RXRalpha; Retinoid X Nuclear Receptor Alpha; Retinoid X Receptor Alpha; RXR-ALPHA; RXRALPHA |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz